In a study, bladder tumors recurred in 14.5% of patients following a five-year tumor-free period.
Preoperative frailty increases the likelihood of postoperative complications among patients undergoing minimally invasive surgery.
This higher level of dialysis care in Canada is partly owed to substantially higher reimbursement fees for nephrologists.
Although several biomarkers show promise, PCA3 has garnered substantial attention following FDA approval and its role in the diagnosis of PCa will grow.
The surgical treatment of urolithiasis has undergone a marked evolution over the past 30 years.
In a small study, metformin slowed progression of metastatic castration-resistant prostate cancer.